- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Investigators of Rutgers IFH Report Teen Overdoses Related to Drugs for Common Mental Health Issues
Researchers of the Rutgers Institute for Health, Health Care Policy, and Aging Research noted that physicians need to weigh the risks and benefits of drugs used to treat common mental health conditions amid reported overdoses.
A study published in Pediatrics, led by researchers of the Rutgers Institute for Health, Health Care Policy, and Aging Research (IFH), showed that a high number of teens and young adults with an overdose involving a benzodiazepine (BZD) or psychostimulant—medications commonly used to treat mental health issues—have a recent medical prescription for a BZD or stimulant.
Findings indicated that 29% of youth with overdoses involving BZD had a doctor-written prescription dispensed in the prior month and 42% in the prior 6 months, whereas 25% of youth with an overdose involving stimulants had a stimulant prescription dispensed in the prior month and 39% in the prior 6 months.
“Given that a substantial proportion of youth with overdoses involving BZD or stimulants have prescriptions for these drugs in the prior months, physician encounters when these medications are prescribed may offer an opportunity to identify youth at high risk of overdose,” said corresponding author Greta Bushnell, a core member of the Center for Pharmacoepidemiology and Treatment Sciences at Rutgers IFH.
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
